DE602007002182D1 - Verfahren zur herstellung von cgrp-antagonisten - Google Patents

Verfahren zur herstellung von cgrp-antagonisten

Info

Publication number
DE602007002182D1
DE602007002182D1 DE602007002182T DE602007002182T DE602007002182D1 DE 602007002182 D1 DE602007002182 D1 DE 602007002182D1 DE 602007002182 T DE602007002182 T DE 602007002182T DE 602007002182 T DE602007002182 T DE 602007002182T DE 602007002182 D1 DE602007002182 D1 DE 602007002182D1
Authority
DE
Germany
Prior art keywords
oxo
preparation
azepan
imidazo
difluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007002182T
Other languages
English (en)
Inventor
Kevin Belyk
Nelo Rivera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE602007002182D1 publication Critical patent/DE602007002182D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602007002182T 2006-04-10 2007-04-06 Verfahren zur herstellung von cgrp-antagonisten Active DE602007002182D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79070406P 2006-04-10 2006-04-10
PCT/US2007/008702 WO2007120591A1 (en) 2006-04-10 2007-04-06 Process for the preparation of cgrp antagonist

Publications (1)

Publication Number Publication Date
DE602007002182D1 true DE602007002182D1 (de) 2009-10-08

Family

ID=38477276

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007002182T Active DE602007002182D1 (de) 2006-04-10 2007-04-06 Verfahren zur herstellung von cgrp-antagonisten

Country Status (10)

Country Link
US (1) US7829699B2 (de)
EP (1) EP2007764B1 (de)
JP (1) JP2009533439A (de)
CN (1) CN101421266A (de)
AT (1) ATE440843T1 (de)
AU (1) AU2007238895A1 (de)
CA (1) CA2649159A1 (de)
DE (1) DE602007002182D1 (de)
ES (1) ES2330166T3 (de)
WO (1) WO2007120591A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011511792A (ja) 2008-02-05 2011-04-14 メルク・シャープ・エンド・ドーム・コーポレイション Cgrp受容体アンタゴニストのプロドラッグ
WO2010144293A1 (en) * 2009-06-08 2010-12-16 Merck Sharp & Dohme Corp. Synthesis of telcagepant and intermediates thereof
CN109400541B (zh) * 2018-04-03 2022-05-17 淮安国瑞化工有限公司 通过1-氯-2-(4-氯苯基)-3-甲基-4-戊烯-2-醇制备环唑醇的方法
EP4074712A1 (de) * 2021-04-13 2022-10-19 Siegfried AG Verfahren zur synthese von 1,3-dihydro-imidazo[4,5-b]pyridin-2-on und/oder derivaten davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2355B1 (en) * 2003-04-15 2006-12-12 ميرك شارب اند دوم كوربوريشن Hereditary calcitonin polypeptide receptor antagonists
CA2649158A1 (en) 2006-04-10 2007-10-25 Merck & Co., Inc. Process for the preparation of pyridine heterocycle cgrp antagonist intermediate
AU2007238896A1 (en) 2006-04-10 2007-10-25 Merck Sharp & Dohme Corp. CGRP antagonist salt
ES2328186T3 (es) 2006-04-10 2009-11-10 MERCK & CO., INC. Procedimiento de preparacion de un intermedio de antagonista del cgrp de caprolactama.

Also Published As

Publication number Publication date
ATE440843T1 (de) 2009-09-15
AU2007238895A1 (en) 2007-10-25
EP2007764A1 (de) 2008-12-31
CN101421266A (zh) 2009-04-29
US20090281306A1 (en) 2009-11-12
EP2007764B1 (de) 2009-08-26
CA2649159A1 (en) 2007-10-25
ES2330166T3 (es) 2009-12-04
US7829699B2 (en) 2010-11-09
WO2007120591A1 (en) 2007-10-25
JP2009533439A (ja) 2009-09-17

Similar Documents

Publication Publication Date Title
EA201001445A1 (ru) ПОЛУЧЕНИЕ 6-АМИНОКАПРОНОВОЙ КИСЛОТЫ ИЗ α-КЕТОПИМЕЛИНОВОЙ КИСЛОТЫ
DE60312701D1 (de) Darstellung von 1h-imidazoä4,5-cüchinolin-4-aminen über neue 1h-imidazoä4,5-cüchinolin-4-cyano- und 1h-imidazoä4,5-cüchinolin-4-carboxamid intermediate
ATE430746T1 (de) Crf-rezeptor-antagonisten und zugehörige verfahren
EA200800727A1 (ru) Введение ингибиторов дипептидилпептидазы
ATE553104T1 (de) Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer
WO2007120590A3 (en) Process for the preparation of pyridine heterocycle cgrp antagonist intermediate
ATE430152T1 (de) Aryl-substituierte diazabicycloalkane als nikotinische acetylcholinagonisten
EA200801757A1 (ru) Пиперидинильные производные в качестве модуляторов активности хемокинового рецептора
MX2009005461A (es) N-oxidos de analogos de 4,5-epoxi-morfinano.
DE602007012910D1 (de) Azetidinverbindungen als orexin-rezeptor-antagonisten
EP2101772A4 (de) Neuromuskuläre blocker mit mittlerer dauer und antagonisten advon
WO2008116665A8 (en) Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
NO20073729L (no) Heterocykliske forbindelser som CCR2B-antagonister
DK2044067T3 (da) Fremgangsmåde til fremstilling af 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octanbromid
HK1091200A1 (en) Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists
MX2008002805A (es) Derivados de carboxamida como antagonistas del receptor muscarinico.
ATE517106T1 (de) Kondensierte spiropiperidine als modulatoren muskarinartiger rezeptoren
DE602007012313D1 (de) Als a2b-adenosinrezeptorantagonisten geeignete 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4,5-büpyridin-2-onderivate
DE602007002182D1 (de) Verfahren zur herstellung von cgrp-antagonisten
NO20092902L (no) 6-benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]kinolinforbindelser nyttige som PDE5-inhibitorer
WO2008002946A3 (en) Method of modulating neurite outgrowth by the use of a galanin-3 receptor antagonist
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
ATE449074T1 (de) 2-azabicyclo 3.3.1 nonan-derivate als antagonisten des opioid-rezeptors
PE20080232A1 (es) Compuestos heterociclicos como antagonistas del receptor cgrp
WO2007066201A3 (en) Chemical compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US